Botanical species · safety record

Senecio vulgaris

The EFSA Compendium of Botanicals holds 7 constituent measurements and 2 adverse-effect records for Senecio vulgaris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Senecio vulgaris L.

7Constituent measurements
2Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Pyrrolizidine alkaloids3
  • Retrorsine1
  • Seneci(o)phylline1
  • Senecionine1
  • Senkirkine1

Plant parts

  • Live plants4
  • Unspecified4
  • Aerial part of plants1

Preparations

  • Solvent extraction8
  • Fresh1

Effect types

  • Hepatotoxicity2

Target tissues

  • Liver2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Pyrrolizidine alkaloidsUnspecifiedSolvent extractionUnspecifiedResolve DOI
Pyrrolizidine alkaloidsLive plantsSolvent extraction0.14 PercentNuclear Magnetic Resonance (NMR)No resolvable identifier
Pyrrolizidine alkaloidsLive plantsSolvent extraction0.16 PercentNuclear Magnetic Resonance (NMR)No resolvable identifier
RetrorsineUnspecifiedSolvent extraction65 Microgram/gramLC-MSNo resolvable identifier
Seneci(o)phyllineUnspecifiedSolvent extraction12.3 Microgram/gramLC-MSNo resolvable identifier
SenecionineUnspecifiedSolvent extraction40 Microgram/gramLC-MSNo resolvable identifier
SenkirkineLive plantsSolvent extraction0.013 Microgram/gramLC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverLive plantsSolvent extractionRat (as animal)Short-term toxicityResolve DOI
HepatotoxicityLiverAerial part of plantsFreshHorse (as animal)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zhou, Yan., Li, Na., Choi, Franky Fung-Kei., Qiao, Chun-Feng., Song, Jing-Zheng., Li, Song-Lin., Liu, Xin., Cai, Zong-Wei., Fu, Peter P., Lin, Ge., et al. A new approach for simultaneous screening and quantification of toxic pyrrolizidine alkaloids in some potential pyrrolizidine alkaloid-containing plants by using ultra performance liquid chromatography-tandem quadrupole mass spectrometry. Analytica Chimica Acta, 2010, p. 33-40.
  2. Lessard P., Wilson W D., Olander H J., Rogers Q R., Mendel V E. Clinicopathologic study of horses surviving pyrrolizidine alkaloid (Senecio vulgaris) toxicosis. American journal of veterinary research, 1986, p. 1776-1780.
  3. Xiong, Aizhen., Fang, Lianxiang., Yang, Xiao., Yang, Fan., Qi, Meng., Kang, Hong., Yang, Li., Tsim, Karl Wah-Keung., Wang, Zhengtao. An application of target profiling analyses in the hepatotoxicity assessment of herbal medicines: comparative characteristic fingerprint and bile acid profiling of Senecio vulgaris L. and Senecio scandens Buch.-Ham. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, vol. 406, no. 29, p. 7715-7727. DOI
  4. Molyneux, Russell J., Johnson, A. Earl., Roitman, James N., Benson, Mabry E. Chemistry of toxic range plants. Determination of pyrrolizidine alkaloid content and composition in Senecio species by nuclear magnetic resonance spectroscopy. Journal of Agricultural and Food Chemistry, 1979, p. 494-499.
  5. Roeder, E., Wiedenfeld, H. Plants containing pyrrolizidine alkaloids used in the Traditional Indian Medicine - including Ayurveda. PHARMAZIE, 2013, vol. 68, no. 2, p. 83-92. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue